JP2019504895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504895A5 JP2019504895A5 JP2018560744A JP2018560744A JP2019504895A5 JP 2019504895 A5 JP2019504895 A5 JP 2019504895A5 JP 2018560744 A JP2018560744 A JP 2018560744A JP 2018560744 A JP2018560744 A JP 2018560744A JP 2019504895 A5 JP2019504895 A5 JP 2019504895A5
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable particles
- composition according
- composition
- encapsulated
- cedar pollen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022059997A JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2025001876A JP2025069142A (ja) | 2016-02-09 | 2025-01-06 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662293261P | 2016-02-09 | 2016-02-09 | |
| US62/293,261 | 2016-02-09 | ||
| PCT/US2017/017248 WO2017139498A1 (en) | 2016-02-09 | 2017-02-09 | Timps encapsulating japanese cedar pollen epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022059997A Division JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019504895A JP2019504895A (ja) | 2019-02-21 |
| JP2019504895A5 true JP2019504895A5 (https=) | 2020-03-19 |
Family
ID=59563413
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560744A Pending JP2019504895A (ja) | 2016-02-09 | 2017-02-09 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2022059997A Pending JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2025001876A Pending JP2025069142A (ja) | 2016-02-09 | 2025-01-06 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022059997A Pending JP2022101576A (ja) | 2016-02-09 | 2022-03-31 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
| JP2025001876A Pending JP2025069142A (ja) | 2016-02-09 | 2025-01-06 | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
Country Status (3)
| Country | Link |
|---|---|
| JP (3) | JP2019504895A (https=) |
| KR (1) | KR20180105243A (https=) |
| WO (1) | WO2017139498A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012021512A2 (en) | 2010-08-10 | 2012-02-16 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| CN105188741A (zh) | 2013-04-03 | 2015-12-23 | 阿勒丁医疗公司 | 新型纳米颗粒组合物 |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| KR102717969B1 (ko) | 2014-02-21 | 2024-10-15 | 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) | 글리코타겟팅 치료제 |
| US20190365656A1 (en) * | 2016-01-04 | 2019-12-05 | Cour Pharmaceuticals Development Company, Inc. | Particles encapsulating fusion proteins containing linked epitopes |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EA202092723A1 (ru) | 2018-05-09 | 2021-04-09 | Зе Юниверсити Оф Чикаго | Композиции и способы, касающиеся иммунной толерантности |
| US12528848B2 (en) | 2018-05-25 | 2026-01-20 | The Wistar Institute Of Anatomy And Biology | Tumor-specific neoantigens and methods of using the same |
| JP6982039B2 (ja) * | 2019-09-24 | 2021-12-17 | 鳥居薬品株式会社 | ヒノキ花粉抗原に対するモノクローナル抗体及びその用途 |
| BR112023021222A2 (pt) * | 2021-04-16 | 2024-01-16 | Cour Pharmaceuticals Dev Company Inc | Método de rastreamento de manutenção de tolerância imunológica |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1932538A4 (en) * | 2005-08-25 | 2009-10-21 | Taiho Pharmaceutical Co Ltd | BIODEGRADABLE NANOTEHICLES WITH IMMOBILIZED OR CAPACITATED T-CELL-RECOGNIZABLE EPITOPEPEPID |
| JP2014524902A (ja) * | 2011-06-14 | 2014-09-25 | アメリカ合衆国 | Ｔｅｍ８抗体、そのコンジュゲートおよびそれらの使用 |
| IL292567B2 (en) * | 2013-08-13 | 2025-06-01 | Univ Northwestern | Peptide conjugated particles |
-
2017
- 2017-02-09 WO PCT/US2017/017248 patent/WO2017139498A1/en not_active Ceased
- 2017-02-09 JP JP2018560744A patent/JP2019504895A/ja active Pending
- 2017-02-09 KR KR1020187025977A patent/KR20180105243A/ko not_active Ceased
-
2022
- 2022-03-31 JP JP2022059997A patent/JP2022101576A/ja active Pending
-
2025
- 2025-01-06 JP JP2025001876A patent/JP2025069142A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504895A5 (https=) | ||
| RU2016107998A (ru) | Частицы, конъюгированные с пептидом | |
| JP2016511747A5 (https=) | ||
| Grego et al. | Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles | |
| Pavot et al. | Poly (lactic acid) and poly (lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery | |
| Petersen et al. | Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen | |
| Singha et al. | Nanoparticles for immune stimulation against infection, cancer, and autoimmunity | |
| Joshi et al. | Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses | |
| RU2014124682A (ru) | Полимерные белковые микрочастицы | |
| Rauta et al. | Parenteral immunization of PLA/PLGA nanoparticle encapsulating outer membrane protein (Omp) from Aeromonas hydrophila: Evaluation of immunostimulatory action in Labeo rohita (rohu) | |
| JP2019507113A5 (https=) | ||
| JP2014533698A5 (https=) | ||
| JP2018503668A5 (https=) | ||
| JP2017538672A5 (https=) | ||
| JP2011520813A5 (https=) | ||
| JP2016509011A5 (https=) | ||
| JP2018500394A5 (https=) | ||
| Mishra et al. | Biodegradable polymer based particulate carrier (s) for the delivery of proteins and peptides | |
| KR20160003212A (ko) | 면역 관용의 유도를 위한 특정된 약역학적 유효 수명을 갖는 면역억제제 및 항원의 전달 | |
| JP2017524682A5 (https=) | ||
| CN114306638A (zh) | 从合成纳米载体中控制释放免疫抑制剂 | |
| JP2016502515A5 (https=) | ||
| Craparo et al. | Application of polymeric nanoparticles in immunotherapy | |
| Walters et al. | Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy | |
| JP2021502807A5 (https=) |